Long-Acting Injectable Antiretroviral Therapy: Coverage and Cost-Sharing Considerations for RWHAP Clients

ACE TA Center

Fact sheet on the different coverage and cost-sharing considerations for LAI ART across public and private payers – including Medicaid, Medicare, and commercial insurance – and provides information to RWHAP recipients and subrecipients so they can help clients navigate access to LAI ART through these different payers.

LAI ART is a form of HIV treatment that is available as an injection, received routinely by an individual (monthly or bi-monthly), and administered by a clinician or other health care professional. LAI ART may be an option for people with HIV who experience barriers related to adherence to once-daily pill regimens, and prefer monthly or bi-monthly injections.

For more information about this fact sheet’s purpose and why it will be helpful to RWHAP recipients and their clients, visit this TargetHIV blog post.

We'd like your feedback

Was this page helpful?
I found this page helpful because the content on the page:
Check all that apply
I did not find this page helpful because the content on the page:
Check all that apply
Please include an email address if you would like a response
Please include an email address if you would like a response